Teva Reports Fourth Quarter and Full Year 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Teva Pharma (TEVA) Gains 7.5% Following Results
February 12, 2020 9:33 AM ESTTeva Pharma (NYSE: TEVA) gains 7.5% off the open following results.
... MoreUPDATE: Teva Pharma (TEVA) Tops Q4 EPS by 1c, Offers FY20 Guidance
February 12, 2020 7:01 AM EST(Updated - February 12, 2020 7:05 AM EST)
Teva Pharma (NYSE: TEVA) reported Q4 EPS of $0.62, $0.01 better than the analyst estimate of $0.61. Revenue for the quarter came in at $4.5 billion versus the consensus estimate of $4.35 billion.
2020 business outlook:
Revenues are... More
